Immunoglobulins: Global Market Outlook
Report Scope:
The scope of this study encompasses the current and forecast markets for normal and hyper immunoglobulins. The report segments markets based on product type and route of administration. The report surveys the competitive landscape, market dynamics and current and developing technologies. The report also analyzes the impact of COVID-19 on the market.
In terms of geographical regions, the report analyzes the market across North America, Europe, Asia-Pacific and the rest of the world (RoW). Key regions such as the U.S., Canada, Europe (U.K., Italy, France and Germany), Asia-Pacific (China, India and Japan) are highlighted in the discussion.
The report also analyzes key companies and their recent developments, such as product launches, business expansions and collaborations.
Report Includes:
A brief general outlook of the global market for immunoglobulins
Analyses of the global market trends, with historic market revenue data (sales figures) for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Estimation of the actual market size and revenue forecast for the global immunoglobulins market in USD million terms, and corresponding market share analysis by product type, route of administration, and region
In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, current and future prospects in therapeutic treatments, and contributions to the overall market
Identification of major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, segmental revenues, and operational integration
Company profiles of the market leading players
Companies Mentioned
ADMA BIOLOGICS INC.
BAXTER INTERNATIONAL
BIO PRODUCTS LABORATORY LTD.
CHINA BIOLOGIC PRODUCTS INC.
CSL LTD.
GRIFOLS INTERNATIONAL S.A.
INNOVATIVE RESEARCH
INTAS PHARMACEUTICALS LTD.
KEDRION SPA
LFB S.A.
OCTAPHARMA AG
SANQUIN
TAKEDA PHARMACEUTICAL COMPANY LIMITED.
- Chapter 1 Introduction
- 1.1 Market Snapshot
- Chapter 2 Executive Summary
- Chapter 3 Market Overview
- 3.1 Immunoglobulin G (IgG)
- 3.2 Immunoglobulin M (IgM)
- 3.3 Immunoglobulin A (IgA)
- 3.4 Immunoglobulin E (IgE)
- 3.5 Immunoglobulin D (IgD)
- 3.6 Immunoglobulins Mechanism of Action
- 3.7 Clinical Use of Immunoglobulins
- 3.7.1 Replacement Therapy with Immunoglobulins
- 3.7.2 Immunoglobulin Blood Tests
- 3.8 Market Dynamics
- 3.8.1 Market Drivers
- 3.8.2 Market Restraints
- Chapter 4 Emerging Technologies/ Opportunities
- 4.1 Growing Investments in Plasma Fractionation Capacities
- 4.2 Increasing Research on New Formulations and Indications
- 4.3 Growing Opportunities in Emerging Nations
- 4.4 Adoption of Digital Initiatives
- Chapter 5 Market Breakdown by Type, Route of Administration
- 5.1 Immunoglobulins Market, by Type
- 5.1.1 Normal Immune Globulins
- 5.1.2 Hyperimmune Globulins
- 5.1.3 Market Size and Forecast
- 5.2 Immunoglobulins Market, by Route of Administration
- 5.2.1 Intravenous (IV) Administration
- 5.2.2 Subcutaneous (SC) Administration
- 5.2.3 Others
- 5.2.4 Market Size and Forecast
- 5.3 Normal Immunoglobulins Market, by Application
- 5.3.1 Primary Immune Deficiency (PID)
- 5.3.2 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- 5.3.3 Secondary Immune Deficiency (SID)
- 5.3.4 Multifocal Motor Neuropathy (MMN)
- 5.3.5 Other Neurological Disorders
- 5.3.6 Other Applications
- 5.3.7 Market Size and Forecast
- Chapter 6 Market Breakdown by Region
- 6.1 Global Immunoglobulins Market Size, by Region
- 6.2 North America
- 6.3 Europe
- 6.4 Asia-Pacific
- 6.5 Rest of the World
- Chapter 7 Competitive Landscape
- 7.1 Recent Key Developments
- 7.2 Product Launches
- 7.3 Mergers and Acquisitions
- 7.4 Business Expansions
- 7.5 Agreements and Collaborations
- 7.6 Clinical Trials Landscape
- Chapter 8 COVID-19 Impact: Immunoglobulins Market
- 8.1 COVID-19 Impact on the Immunoglobulins Market
- 8.1.1 Convalescent Plasma (CP) Therapy and Hyperimmune Globulins for COVID-19 Treatment
- Chapter 9 Company Profiles
- ADMA BIOLOGICS INC.
- BAXTER INTERNATIONAL
- BIO PRODUCTS LABORATORY LTD.
- CHINA BIOLOGIC PRODUCTS INC.
- CSL LTD.
- GRIFOLS INTERNATIONAL S.A.
- INNOVATIVE RESEARCH
- INTAS PHARMACEUTICALS LTD.
- KEDRION SPA
- LFB S.A.
- OCTAPHARMA AG
- SANQUIN
- TAKEDA PHARMACEUTICAL COMPANY LIMITED.
- Chapter 10 Project Scope and Methodology
- 10.1 Scope of Report
- 10.2 Methodology
- 10.3 Analyst's Credentials
- 10.4 BCC Custom Research
- 10.5 Related BCC Research Reports
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook